What is the main function of avatrombopag maleate/Sucoxin?

Avatrombopag is a new oral thrombopoietin receptor agonist ( TPO-RA). Its main function is to promote the differentiation and maturation of bone marrow megakaryocytes by selectively activating the thrombopoietin receptor, thereby accelerating the production and release of platelets, and ultimately increasing the platelet level in the blood. Different from traditional blood transfusion or hormone therapy, it improves the body's hematopoietic function from the source and is an important breakthrough in the field of thrombocytopenia treatment in recent years.

The core application areas of avatrombopag include chronic immune thrombocytopenia (ITP) and chronic liver disease-related thrombocytopenia. For ITP patients, the drug can help break through the limitations of immune destruction of platelets, promote a steady increase in platelets, and reduce the risk of bleeding; for patients with chronic liver disease who are about to undergo surgery or interventional procedures, early use of avatrombopag can significantly improve platelet levels, thereby reducing the risk of perioperative bleeding caused by insufficient platelets.

Pharmacologically, the unique advantage of avatrombopag is that it does not significantly interact with diet and can be taken with meals, increasing compliance. In addition, it acts on receptors through small molecules, avoiding immune tolerance problems caused by antibody formation, which makes it more stable and safe for long-term use. Compared with some treatment methods that require injections or dietary restrictions, avatrombopag is more convenient for patients.

It should be noted that the main function of avatrombopag is to "increase and maintain platelet levels", but it cannot reverse the underlying mechanism that causes thrombocytopenia, so it is more of a long-term management drug than a complete cure. Doctors usually dynamically adjust the dose based on the patient's platelet count to ensure that a safe level is maintained without being too high to cause the risk of blood clots.

Reference materials:https://go.drugbank.com/drugs/DB11995

xa0